Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Search this blog
Best Practices for Post-Market Surveillance Processes
Posted on November 13th, 2015 by Neal Katz in Pharmacovigilance
Donna Sees, an Information Consultant with PharmIntell Consulting, has been a librarian in the medical field for more than 10 years. In this article, she discusses post-market surveillance processes and best practices for medical device companies.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.